pacemaker

Long-term septal ablation in hypertrophic cardiomyopathy

Original title:&nbsp;Periprocedural Complication and Long-Term Outcome After Alcohol Septal ablation in hypertrofic Obstructive cardiomyopathy. A Single-Center Experience.&nbsp;Reference:&nbsp;Robbert Steggerda, et al. J Am Coll Cardiol Intv 2014;7:1227-34. Septal ablation is an alternative to surgery in hypertrophic cardiomyopathy (HCM), but indications and evolution are not fully established.161 patients who received septal ablation (SA) and 102 who received<a href="https://solaci.org/en/2014/12/29/long-term-septal-ablation-in-hypertrophic-cardiomyopathy/" title="Read more" >...</a>

TAVR: Regression of Left Ventricular Hypertrophy Decreases Re-hospitalization

Original title:&nbsp;Early Regression of Severe Left Ventricular Hypertrophy After Transcatheter Aortic Valve Replacement Is Associated with Decreased Hospitalization.&nbsp;Reference:&nbsp;Brian Lindman, et al. JACC Cardiovasc Interv 2014;7:662-73. &nbsp; Left ventricular hypertrophy, defined by the increase of left ventricular mass, has long been associated to increased morbi-mortality in the context of different heart conditions. LV hypertrophy regression might<a href="https://solaci.org/en/2014/08/05/tavr-regression-of-left-ventricular-hypertrophy-decreases-re-hospitalization/" title="Read more" >...</a>

Septal ablation, a valid alternative for obstructive hypertrophic cardiomyopathy

Original title:&nbsp;Survival of Patients &le;50 Years Alter Alcohol Septal Ablation for Hypertrofic Obstructive Cardiomyopathy.&nbsp;Reference:&nbsp;Josef Veselka, et al. Canadian Journal of Cardiology 2014,30:634-638 Treatment of symptomatic obstructive hypertrophic cardiomyopathy (HCM) is the surgical septal myomectomy nevertheless, currently arose several studies reporting a favourable evolution and comparable to surgery with septal ablation (AS). 75 patients under 50<a href="https://solaci.org/en/2014/07/15/septal-ablation-a-valid-alternative-for-obstructive-hypertrophic-cardiomyopathy/" title="Read more" >...</a>

TVAR live edited broadcasts are safe.

Original title:&nbsp;The impact of live transmition on patients outcomes during transcatheter aortic valve replacement: Results fron the VERITAS study.&nbsp;Reference:&nbsp;Ron Waskman, et al. Cardiovascular Revascularization Medicine 2014;15:63-68 &nbsp; With the advancement of medical technology and the great development of telecommunications, performing live or edited cases has become a common occurrence in medical education, but one of<a href="https://solaci.org/en/2014/04/11/tvar-live-edited-broadcasts-are-safe/" title="Read more" >...</a>

Core Valve in high-risk patients, superior to surgical replacement at one year

Original title:&nbsp;Transcatheter Aortic-Valve Replacement with a Self-Expanding Prosthesis.&nbsp;Reference:&nbsp;David H. Adams et al. N Engl J Med. 2014 Mar 29. [Epub ahead of print]. Transcatheter Aortic valve replacement (TAVR) with balloon expandable valve showed survival improvement in inoperable patients and was similar to surgery inoperable high-risk patients. An alternative to the above device is the self-expandable<a href="https://solaci.org/en/2014/04/09/core-valve-in-high-risk-patients-superior-to-surgical-replacement-at-one-year/" title="Read more" >...</a>

The complete Left Bundle Branch Block after TAVI is not associated with increased mortality at 12 months

Original title:&nbsp;Impact of New-Onset Persistent Left Bundle Branch Block on late Clinical Outcomes in Patients Undergoing Trancatheter Aortic Valve implantation with a Balloon &ndash;Expandable Valve.&nbsp;Reference:&nbsp;Urena Marina, el al. JACC Cardiovasc Interv. 2014 Feb;7(2):128-36. Percutaneous aortic valve implantation brings, sometimes the presence of permanent left bundle branch block (LBBB) that has been associated in some series<a href="https://solaci.org/en/2014/03/18/the-complete-left-bundle-branch-block-after-tavi-is-not-associated-with-increased-mortality-at-12-months/" title="Read more" >...</a>

Implanting a second valve and embolization are two complications that increase mortality

Original title: Determinats and Outcomes of Acute transcatheter Valve-in Valve Therapy or Embolization.&nbsp;Reference:&nbsp;Raj R Makkar, et al. J Am Coll Cardiol 2013;62:418-30 &nbsp; Percutaneous aortic valve implantation has proven to be feasible, safe and a successful follow up. Only in a few patients is the two-valve implantation necessary due to bad positioning or embolism but<a href="https://solaci.org/en/2013/08/06/implanting-a-second-valve-and-embolization-are-two-complications-that-increase-mortality/" title="Read more" >...</a>

Aortic Valvuloplasty in the transcatheter aortic valve implantation era 

Original title:&nbsp;Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era.&nbsp;Reference:&nbsp;Francesco Saia et al. EuroIntervention 2013;8:1388-1397 Until a few years ago, aortic valvuloplasty had been abandoned by many centers due to its limited results and frequent complications. The current guidelines recommend aortic valvuloplasty to treat patients with symptomatic<a href="https://solaci.org/en/2013/05/21/aortic-valvuloplasty-in-the-transcatheter-aortic-valve-implantation-era/" title="Read more" >...</a>

Post TAVI Hypertension is a predictor of better evolution

Original title:&nbsp;Post-Procedural Hypertension Following Transcatheter Aortic Valve Implantation Incidence and Clinical Significance.&nbsp;Reference:&nbsp;Gidon Y. Perlman et al. J Am Coll Cardiol Intv 2013. Article in press. Pre-procedural hypertension (HTN) is a risk factor and a predictor of increased mortality after surgical aortic valve replacement (AVR). The disappearance of the pressure gradient across the aortic valve following<a href="https://solaci.org/en/2013/05/02/post-tavi-hypertension-is-a-predictor-of-better-evolution/" title="Read more" >...</a>

Valve-in-Valve Implantation Is Possible

Original title:&nbsp;5 Years Experience With Trancatheter Tranaspical Mitral Valve &ndash;in Valve Implantation for Bioprosthetic Valve Dysfunction&nbsp;Reference:&nbsp;Anson Cheung et al. J Am Coll Cardiol 2013;61:1759&ndash;66. Percutaneous valves development, first aortic and now mitral, has brought an opportunity to improve life quality and extend life for high risk non-surgical patients. 23 patients received transapical implantation in mitral<a href="https://solaci.org/en/2013/04/29/valve-in-valve-implantation-is-possible/" title="Read more" >...</a>

Top